Coronavirus Infections
Showing NaN - NaN of 6
Coronavirus Infections Trial in Moscow (tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab)
Active, not recruiting
- Coronavirus Infections
- tixagevimab/cilgavimab 150+150 mg
- +2 more
-
Moscow, Russian FederationMoscow City Clinical Hospital 52
Aug 7, 2023
COVID-19, Coronavirus Infections, Respiratory Tract Infections Trial in Russian Federation (Subunit recombinant vaccine for the
Active, not recruiting
- COVID-19
- +3 more
- Subunit recombinant vaccine for the prevention of coronavirus infection
- Placebo
-
Moscow, Russian Federation
- +5 more
Feb 9, 2023
Coronavirus Infections, Vaccine Trial in Russian Federation (CoviVac vaccine (inactivated whole-virion concentrated purified)
Recruiting
- Coronavirus Infections
- Vaccine
- CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS"
- The data from volunteers from the control group
-
Kirov, Russian Federation
- +9 more
Jul 8, 2022
COVID-19, Immunologic Factors, Coronavirus Infections Trial in Moscow, Saint-Petersburg (Subunit recombinant vaccine for the
Active, not recruiting
- COVID-19
- +3 more
- Subunit recombinant vaccine for the prevention of coronavirus infection
- Placebo
-
Moscow, Russian Federation
- +2 more
Dec 15, 2021
Coronavirus Infections, Vaccine Trial in Russian Federation (Vaccine for intramuscular injection, Placebo comparator (without
Completed
- Coronavirus Infections
- Vaccine
- Vaccine for intramuscular injection
- Placebo comparator (without active ingredient) for intramuscular injection
-
Kirov, Russian Federation
- +4 more
Nov 11, 2021
Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in
Recruiting
- Coronavirus Infections
- Pneumonia
- Chest MRI
-
Moscow, Russian FederationResearch and Practical Clinical Center for Diagnostics and Telem
Dec 8, 2020